OrthoClinical Diagnostics News

Half of the $1 million commitment will be used as an unrestricted gift, and the other half for math and science scholarships.

Goldman Sachs released a report highlighting the companies with the largest short positions among hedge funds.

Johnson & Johnson shares have pulled back with the markets and now can be bought near the 52-week lows.

The single, easiest way to keep track of all the stocks that matter... Your own personalized stock watchlist! It's a 100% FREE Motley Fool service... ) Xarelto -- the blood thinner is already approved to prevent blood clots after surgery and to treat arterial fibrillation, a type of irregular heart beat -- but it could be the most important.

Pharmaceuticals giant Elan could have a "path to market" for a new drug that would "transform" the company by the end of this year, the company said yesterday.

Betty DeGeneres, Ellen DeGeneres' mom, is featured in a video promoting a campaign in support of Parents, Families & Friends of Lesbians and Gays anti-bullying efforts.

Johnson & Johnson , one of the world's leaders in the pharmaceutical, medical devices, and general consumer products industries, is a supreme opportunity for long-term value investors.

This will help sooth your kids' booboos: Johnson & Johnson has just introduced an augmented reality app that projects image of the Muppets on their Band-Aids. As the video above shows, the iOS-based app, co-developed by JWT , can prompt a song from Kermit the Frog, a red carpet entry by Miss Piggy or a "daring act of lunacy" from Gonzo.

Hedge funds turned their backs on Johnson & Johnson and Amazon.com Inc in the last months, kicking the former market darlings into a group where they see stock prices dropping, research from Goldman Sachs shows.

The following video is part of our "Motley Fool Conversations" series, in which consumer goods editor/analyst Austin Smith and senior technology analyst Eric Bleeker discuss topics across the investing world.

Should you invest in a giant healthcare company that has managed to shoot itself in the foot over and over again in recent years? Alex Gorsky, who recently took over as CEO of Johnson & Johnson , faces a sea of problems that have damaged the company's reputation.

Johnson & Johnson is an excellent company that you should be pleased to own. It has good fundamentals, but recently the price has begun to pull back.

The markets are still in a corrective mode, and we believe that we will need to see one more selling climax, followed by 1-2 days where the market closes in the red on lower volume.

Johnson & Johnson said its drug Simponi improved symptoms in a majority of patients with an inflammatory-bowel disease in a new clinical trial.

Johnson & Johnson has been providing the Southeastern NC region with the highest quality legal services since 1985.

By MATTHEW PERRONE AP Health Writer WASHINGTON - The Food and Drug Administration said Monday that a blood thinner from Johnson & Johnson appears to reduce life-threatening blood clots in high-risk patients, although it also increases the risk of internal bleeding.

The Food and Drug Administration says a blood thinner from Johnson & Johnson appears to reduce life-threatening blood clots in high-risk patients, although it also increases the risk of internal bleeding.

The Food and Drug Administration says a blood thinner from Johnson & Johnson appears to reduce life-threatening blood clots in high-risk patients, although it also increases the risk of internal bleeding.

Johnson & Johnson and Bayer AG 's blood-thinner Xarelto was recommended for approval to prevent heart attacks by a reviewer for U.S. regulators.

Johnson & Johnson has won the first-ever monopolistic dispute between a producer and dealer on the Chinese mainland, with the court rejecting the dealer's compensation request of 14 million yuan , said Shanghai No.1 Intermediate People's Court.